IL70199A0 - Substituted 6,7-dihydro-1-oxo-1h,5h-benzo(i)quinolizine-2-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them - Google Patents
Substituted 6,7-dihydro-1-oxo-1h,5h-benzo(i)quinolizine-2-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL70199A0 IL70199A0 IL70199A IL7019983A IL70199A0 IL 70199 A0 IL70199 A0 IL 70199A0 IL 70199 A IL70199 A IL 70199A IL 7019983 A IL7019983 A IL 7019983A IL 70199 A0 IL70199 A0 IL 70199A0
- Authority
- IL
- Israel
- Prior art keywords
- quinolizine
- benzo
- dihydro
- oxo
- derivatives
- Prior art date
Links
- OVMCSDQWFSMOIT-UHFFFAOYSA-N 1-oxo-6,7-dihydro-4H-benzo[j]quinolizine-2-carboxylic acid Chemical class O=C1C(=CCN2CCC=C3C12C=CC=C3)C(=O)O OVMCSDQWFSMOIT-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/441,246 US4472406A (en) | 1982-11-12 | 1982-11-12 | Antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL70199A0 true IL70199A0 (en) | 1984-02-29 |
Family
ID=23752115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL70199A IL70199A0 (en) | 1982-11-12 | 1983-11-11 | Substituted 6,7-dihydro-1-oxo-1h,5h-benzo(i)quinolizine-2-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4472406A (fi) |
| EP (1) | EP0109285A1 (fi) |
| JP (1) | JPS59101467A (fi) |
| KR (1) | KR840006660A (fi) |
| AU (1) | AU2118283A (fi) |
| ES (1) | ES8702405A1 (fi) |
| FI (1) | FI834148A (fi) |
| GR (1) | GR79367B (fi) |
| IL (1) | IL70199A0 (fi) |
| NO (1) | NO834094L (fi) |
| NZ (1) | NZ206234A (fi) |
| OA (1) | OA07585A (fi) |
| PL (1) | PL244509A1 (fi) |
| PT (1) | PT77650B (fi) |
| ZA (1) | ZA838439B (fi) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE34392T1 (de) * | 1983-10-17 | 1988-06-15 | Synthelabo | Imidazolinderivate, ihre herstellung und therapeutische verwendung. |
| DE3411997A1 (de) * | 1984-03-31 | 1985-10-17 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue redox-indikatoren |
| US4550103A (en) * | 1984-07-20 | 1985-10-29 | Warner-Lambert Company | Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids |
| US6750224B1 (en) | 1999-05-07 | 2004-06-15 | Wockhardt Limited | Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| EP1175217B8 (en) | 1999-05-07 | 2009-03-18 | Wockhardt Limited | (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents |
| US6514986B2 (en) | 2000-11-22 | 2003-02-04 | Wockhardt Limited | Chiral fluoroquinolone arginine salt forms |
| US6608078B2 (en) | 2000-05-08 | 2003-08-19 | Wockhardt Limited | Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment |
| US7098219B2 (en) | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
| US6878713B2 (en) * | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6964966B2 (en) | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6664267B1 (en) | 2002-05-28 | 2003-12-16 | Wockhardt Limited | Crystalline fluoroquinolone arginine salt form |
| US7164023B2 (en) * | 2003-09-04 | 2007-01-16 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| US10815224B2 (en) * | 2016-07-14 | 2020-10-27 | Bristol-Myers Squibb Company | Monocyclic heteroaryl substituted compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE793524A (fr) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
| JPS6019910B2 (ja) * | 1979-10-11 | 1985-05-18 | 大塚製薬株式会社 | ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸誘導体及びその製造法 |
| JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
| NO156828C (no) * | 1980-11-10 | 1987-12-02 | Otsuka Pharma Co Ltd | Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser. |
| JPS5788182A (en) * | 1980-11-21 | 1982-06-01 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazinecarboxylic acid derivative |
| PT74145B (en) * | 1980-12-18 | 1983-05-30 | Otsuka Pharma Co Ltd | Process for preparing benzoheterocyclic compounds |
| US4404207A (en) * | 1981-11-06 | 1983-09-13 | Riker Laboratories, Inc. | Antimicrobial 8-substituted benzo [IJ]quinolizines |
-
1982
- 1982-11-12 US US06/441,246 patent/US4472406A/en not_active Expired - Fee Related
-
1983
- 1983-11-09 NO NO834094A patent/NO834094L/no unknown
- 1983-11-10 ES ES527165A patent/ES8702405A1/es not_active Expired
- 1983-11-10 OA OA58155A patent/OA07585A/xx unknown
- 1983-11-11 AU AU21182/83A patent/AU2118283A/en not_active Abandoned
- 1983-11-11 NZ NZ206234A patent/NZ206234A/en unknown
- 1983-11-11 PT PT77650A patent/PT77650B/pt unknown
- 1983-11-11 GR GR72948A patent/GR79367B/el unknown
- 1983-11-11 JP JP58212305A patent/JPS59101467A/ja active Pending
- 1983-11-11 EP EP83306909A patent/EP0109285A1/en not_active Withdrawn
- 1983-11-11 IL IL70199A patent/IL70199A0/xx unknown
- 1983-11-11 ZA ZA838439A patent/ZA838439B/xx unknown
- 1983-11-11 PL PL24450983A patent/PL244509A1/xx unknown
- 1983-11-11 FI FI834148A patent/FI834148A/fi not_active Application Discontinuation
- 1983-11-12 KR KR1019830005377A patent/KR840006660A/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR840006660A (ko) | 1984-12-01 |
| ES527165A0 (es) | 1987-01-01 |
| FI834148A (fi) | 1984-05-13 |
| EP0109285A1 (en) | 1984-05-23 |
| PT77650A (en) | 1983-12-01 |
| PL244509A1 (en) | 1985-01-16 |
| PT77650B (en) | 1986-03-27 |
| JPS59101467A (ja) | 1984-06-12 |
| NZ206234A (en) | 1986-10-08 |
| AU2118283A (en) | 1984-05-17 |
| US4472406A (en) | 1984-09-18 |
| OA07585A (fr) | 1985-03-31 |
| ZA838439B (en) | 1985-06-26 |
| FI834148A0 (fi) | 1983-11-11 |
| NO834094L (no) | 1984-05-14 |
| ES8702405A1 (es) | 1987-01-01 |
| GR79367B (fi) | 1984-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL65963A0 (en) | Bis-triazole derivative and salts thereof,their preparation and pharmaceutical compositions containing them | |
| IL69347A0 (en) | Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL69601A0 (en) | Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| MY8500683A (en) | Octahydro pyrazolo (3,4g) quinolines, process for their preparation and pharmaceutical compositions containing them | |
| IL65076A (en) | 3,4-dihydro-5h-2,3-benzo-diazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| GB2091262B (en) | 3-aminoprpoxyaryl derivatives their preparation and pharmaceutical compositions containing them | |
| IL66606A (en) | 4-oxo-3h-imizado(5,1-d)1,2,3,5-tetrazine-8-carboxamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL72471A0 (en) | Pharmaceutical compositions containing phenylquinoline-carboxylic acids and derivatives thereof,certain such novel compounds and their preparation | |
| DE3275296D1 (en) | Azabicyclo-(3,3,1)-nonylbenzamide derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| IL70199A0 (en) | Substituted 6,7-dihydro-1-oxo-1h,5h-benzo(i)quinolizine-2-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| IL85290A0 (en) | Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same | |
| IL65247A0 (en) | Amido-amino acids,process for their preparation and pharmaceutical compositions containing them | |
| ZA862141B (en) | Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them | |
| IL64732A0 (en) | Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3573428D1 (en) | Novel delta4- and delta5- androstene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives | |
| PT76870A (en) | Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them | |
| IL75603A0 (en) | 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL73278A0 (en) | Pharmaceutical compositions containing 1,2-dithiolan derivatives,certain such derivatives and their preparation | |
| IL61675A0 (en) | N-substituted -amino acids and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| ZA862943B (en) | 12b-substituted 1-hydroxymethyl-octahydroindolo-(2,3-a)quinolizine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL69848A0 (en) | 15-cycloaliphatic derivatives of 11,14-didehydrocarboprostacyclins,their preparation and pharmaceutical compositions containing them | |
| IL68005A0 (en) | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA862942B (en) | 1,12b-disubstituted octahydroindolo(2,3-a)-quinolizine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL68520A0 (en) | 5-oxo-2-pyrrolidinepropanoic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| IL75527A (en) | 5,6-dihydro-4h-cyclopenta(b)thiophene-6-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them |